Report Highlights
The global market for immunotherapy drugs should grow from $139.8 billion in 2020 to $204.4 billion by 2025, at compound annual growth rate (CAGR) of 7.9% for the period of 2020-2025.
Report Includes
- 20 data tables and 26 additional tables
- An overview of the global market for immunotherapy drugs
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) though 2025
- Evaluation of current market size and forecast, pipeline analysis of new products, and regulatory scenarios and detailed analysis of drivers, challenges, and opportunities affecting market growth
- Description of immunotherapy, combination immunotherapy and discussion on how it targets on cell-mediated adaptive immunity
- Market share analysis of the immunotherapy drugs based on type of drug, therapy area, end user and region
- Information on personalized treatment paradigm, details of clinically significant types of cancers and discussion on future of immunotherapy in cancer
- Details of checkpoint inhibitors, monoclonal antibodies, interleukins and interferons; and coverage of innovative strategies and novel targeted approaches for immunotherapy
- Discussion on fine tuning versus boosting cancer immunity and early versus advanced stage cancer immunotherapy
- Market share analysis of the major players in the industry, and discussion on their technological strengths and weakness, and innovative marketing practices
- Comprehensive company profiles of major players of the industry, including Amgen Inc., Bayer AG, Johnson & Johnson, Novartis AG and Pfizer Inc.
Report Scope
The global immunotherapy market can be segmented into the following types: checkpoint inhibitors, monoclonal antibodies, interferons and interleukins. This report does not include other immunotherapies such as vaccines and hormones.
The scope of the report includes an overview of the global market and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.
The report discusses technological, regulatory and economic trends that are affecting the market. It also explains the major drivers and regional dynamics of the global market and current trends within the industry.
Regional analysis includes North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy and Rest of Europe), Asia-Pacific (China, India, Japan and Rest of Asia-Pacific) and rest of the world (RoW).
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- AI Impact on Intravenous (IV) Therapy and Vein Access Market- BCC Pulse Report (AIT243A)
- Intravenous (IV) Therapy and Vein Access: Global Markets (HLC046G)
- AI Impact on Hydrogen Technology Testing, Inspection and Certification Market - BCC Pulse Report (AIT183A)
- Global Hydrogen Technology Testing, Inspection and Certification Market (FCB082A)
- AI Impact on Gene Transfer Technologies Market - BCC Pulse Report (AIT202A)
Related Reports
2025 Diagnostics Research Review
Discover the 2025 Diagnostics Research Review from BCC Research with insights into diagnostics market trends, emerging technologies and strategic opportunities.
Global Markets for Allergy Diagnostics and Treatments
The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Cancer Immunotherapy: Technologies and Global Markets
The global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Vaccine Adjuvants Market
This report provides an analysis of the global market for vaccine adjuvants. It focuses on the key driving trends and challenges. The study evaluates the competitive landscape, reviews key technological developments, and provides market estimates and forecasts through 2031.
Global Topical Drug Delivery Market
The global topical drug delivery market was valued at $222.9 billion in 2025 and is estimated to increase from $239 billion in 2026 to reach $362.3 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031.
Blood Cancer Therapeutics: Global Markets to 2030
The global market for blood cancer therapeutics was valued at $77.1 billion in 2025 and is projected to reach $125.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
Clinical Nutrition: Global Markets to 2031
The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.
Substance Use Disorder Treatment: Global Markets to 2030
The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.
Top Trending Reports
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Global Markets for Fermentation Ingredients
The global market for fermentation ingredients is expected to grow from $39.8 billion in 2026 and is projected to reach $53.4 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2026 to 2031.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Global Enterprise Artificial Intelligence (AI) Market
This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.
The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
The U.S. market for biodefense-related rapid pathogen identification and treatments is expected to grow from $8.4 billion in 2026 and is projected to reach $12.1 billion by the end of 2031, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2026 to 2031.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More